Patents by Inventor Scott M. Lonning

Scott M. Lonning has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Combination therapy for treating breast cancer
    Patent number: 8911736
    Abstract: The invention provides compositions and methods for treating breast cancer. Specifically, the invention relates to administering a Transforming Growth Factor beta (TGF?) antagonist in combination with capecitabine and ixabepilone to treat breast cancer.
    Type: Grant
    Filed: March 8, 2011
    Date of Patent: December 16, 2014
    Assignee: Genzyme Corporation
    Inventors: Jay Harper, Scott M. Lonning, Frank James Hsu
  • COMBINATION THERAPY FOR TREATING BREAST CANCER
    Publication number: 20130034549
    Abstract: The invention provides compositions and methods for treating breast cancer. Specifically, the invention relates to administering a Transforming Growth Factor beta (TGF?) antagonist in combination with capecitabine and ixabepilone to treat breast cancer.
    Type: Application
    Filed: March 8, 2011
    Publication date: February 7, 2013
    Inventors: Jay Harper, Scott M. Lonning, Frank James Hsu